Tofacitinib lowers risk of death or respiratory failure in COVID-19 pneumonia: NEJM Hina Zahid18 Jun 2021 11:49 AM ISTResearchers have found in a new study that among patients hospitalized with Covid-19 pneumonia, tofacitinib led to a lower risk of death or...
Tofacitinib is Effective in the Treatment of Ankylosing spondylitis MD Bureau5 Jun 2021 9:00 AM ISTThe Assessment of SpondyloArthritis international Society (ASAS)/European League Against Rheumatism and American College of Rheumatology/Spondylitis...
Tofacitinib Does not Raise risk of VTE in Rheumatoid Arthritis Patients: Study MD Bureau5 April 2021 2:00 PM ISTVenous thromboembolism (VTE), which includes deep venous thrombosis (DVT) and pulmonary embolism (PE), is a common medical problem with an annual...
Arthritis Drug linked to Heart-Related Problems and Cancer by FDA Dr Kartikeya Kohli8 Feb 2021 2:34 PM ISTThe US Food and Drug Administration has issued a warning against the use of tofacitinib, sold under the brand name Xeljanz and Xeljanz XR. The...
Tofacitinib may induce hair regrowth in over 80 percent children with alopecia: Study Medha Baranwal2 Feb 2021 10:15 PM ISTAustralia: Oral tofacitinib may be an effective and well-tolerated treatment strategy for in some children with alopecia areata (AA), suggests a...
Dermatologists can now Prescribe Tofacitinib: CDSCO Committee MD Bureau19 Jan 2021 5:38 PM ISTNew Delhi: In the latest development Pfizer has earned approval from the Central Drugs Standard Control Organization (CDSCO) committee regarding the...
Tofacitinib may benefit Psoriatic Arthritis patients as monotherapy: LANCET study Dr. Nandita Mohan24 Dec 2020 10:15 AM ISTAccording to recent research, it has been observed that some patients with psoriatic arthritis who are stable on tofacitinib 5 mg twice daily with...
Tofacitinib a potential treatment for sarcoidosis: Study Medha Baranwal13 Nov 2020 3:45 PM ISTAustralia: Tofacitinib, a JAK inhibitor, could be used for the treatment of sarcoidosis, suggests a recent study in the Journal of the American...
Tofacitinib use in Ulcerative Colitis may not raise cardiac risk, finds study Dr Satabdi Saha19 Oct 2020 6:00 PM ISTIn a recent study published in Inflammatory Bowel Diseases, researchers have highlighted that Lipid levels and ratios generally unchanged from...
Pfizer arthritis drug Xeljanz gets USFDA okay Ruchika Sharma2 Oct 2020 10:00 AM ISTNew York: Pfizer Inc. has recently announced that the United States (U.S.) Food and Drug Administration (FDA) has approved...
FDA-approved drugs promise new hair growth Meghna A Singhania25 Oct 2015 11:29 PM ISTNew York: There is good news for people suffering from hair loss. In experiments with mouse and human hair follicles, researchers have found that...
India rejects patent claim to Pfizer Pooja Bhatia Bhatia8 Sept 2015 10:48 AM ISTIndia has reportedly again denied Pfizer a patent of rheumatoid arthritis drug tofacitinibPfizer has reportedly sought a patent right over rheumatoid...
